Professor, Internal Medicine, University of Michigan Medical School
Internal Medicine
Dr. Daniel R. Couriel, MD
|
|
Give Review
Daniel Couriel works in the field of Internal Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Daniel Couriel is a published physician. He has 37 publications published. The most current publication "Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial." Daniel Couriel accepts all Medicare patients.
Publications
- Combination Therapy for GVHD Prophylaxis with Etanercept and Extracorporeal Photopheresis: Results of a Phase II Clinical Trial.
- Quantitative Analysis of MR Imaging to Assess Treatment Response for Patients with Multiple Myeloma by Using Dynamic Intensity Entropy Transformation: A Preliminary St...
- FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML.
- Reducing Treatment-related Mortality Did Not Improve Outcomes of Allogeneic Myeloablative Hematopoietic Cell Transplantation for High-Risk Multiple Myeloma: A Universi...
- Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for Acute myeloid leukemia in rem...
- Predictive Value of Bronchiolitis Obliterans Syndrome Stage 0p in Chronic Graft-versus-Host Disease of the Lung.
- The role of extracorporeal photochemotherapy in Chronic graft-versus-host disease.
- Increasing incidence of Chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.
- National Institutes of Health State of the Science Symposium in Therapeutic Apheresis: Scientific Opportunities in Extracorporeal Photopheresis.
- Musculoskeletal, Neurologic, and Cardiopulmonary Aspects of Physical Rehabilitation in Patients with Chronic Graft Versus Host Disease.
- Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy.
- Double umbilical cord blood transplantation after novel myeloablative conditioning using a regimen of fludarabine, busulfan, and total lymphoid irradiation.
- Etanercept plus Topical Corticosteroids as Initial Therapy for Grade One Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
- Parametric Response Mapping as an Indicator of Bronchiolitis Obliterans Syndrome following Hematopoietic Stem Cell Transplantation.
- Plasma CXCL9 elevations correlate with Chronic GVHD diagnosis.
- Vorinostat plus tacrolimus and mycophenolate to prevent Graft-versus-host disease after related-donor reduced-intensity conditioning allogeneic haemopoietic stem-cell ...
- Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia: To Whom, When, and How.
- ST2 as a marker for risk of therapy-resistant Graft-versus-host disease and death.
- High incidence of vitamin D deficiency in patients undergoing allogeneic stem Cell transplantation.
- Fludarabine, Melphalan, Thiotepa and ATG Conditioning for Unrelated Cord Blood Transplantation.
- Comparison of short-term response and long-term outcomes after initial systemic treatment of Chronic graft-versus-host disease.
- Steroid-Refractory Acute GVHD: Predictors and Outcomes.
- A phase III study of infliximab and corticosteroids for the initial treatment of Acute graft-versus-host disease.
- Interleukin-2 and granulocyte-macrophage-colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem Cell transplantation ...
- Blocking LFA-1 activation with lovastatin prevents Graft-versus-host disease in mouse bone marrow transplantation.
- Extracorporeal photopheresis: past, present, and future.
- Chronic graft-versus-host disease after allogeneic stem cell transplantation: challenges in prevention, science, and supportive care.
- Deletion of the short arm of chromosome 1 (del 1p) is a strong predictor of poor outcome in Myeloma patients undergoing an autotransplant.
- HyperAcute GVHD: risk factors, outcomes, and clinical implications.
- Cutaneous manifestations of Chronic graft-versus-host disease.
- Extracorporeal photochemotherapy for the treatment of steroid-resistant Chronic GVHD.
- Novel approaches to the therapy of steroid-resistant Acute graft-versus-host disease.
- Images in cardiovascular medicine. Constrictive pericarditis in a patient with relapsed Acute myelogenous leukemia after allogeneic bone marrow transplantation.
- Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation.
- Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem Cell transp...
- Reduced-intensity conditioning for unrelated donor hematopoietic stem cell transplantation as treatment for Myeloid malignancies in patients older than 55 years.
Schools
University of Buenos Aires Faculty of Medicine
University De Buenos Aires
Geo Washington University
NIH
St Elizabeths Med Center Tufts University School Med
Procedures Preformed
- HPC Transplantation (Stem Cell Transplant)
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anemia
- Antiphospholipid Syndrome (APS)
- Bladder Cancer
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
- Internal Medicine
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
George Washington University -
National Institutes of Health Clinical Center -
St Elizabeth's Medical Center -
University of Buenos Aires
Hospital
-
University of Michigan Hospitals and Health Centers -
University of Utah Health Care - Hospital and Clinics
Drug Facts
| NPI NUMBER | 1275627309 | |
| NPPES Provider LastName | COURIEL | |
| NPPES Provider FirstName | DANIEL | |
| NPPES Provider ZIPCode | 481099814 | |
| NPPES Provider State | MI | |
| Specialty Description | Hematology | |
| Total Claim Count | 984.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 36.0 | |
| Percent Opioid Claims | 3.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1275627309 |
| Last Name Of The Provider | COURIEL |
| First Name Of The Provider | DANIEL |
| View All |
Similar Doctors
|
|
Dr. Paul J. Grant, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhammad M. Alam, MD |
|
|
Dr. Ran Lee, MD |
|
|
Dr. Rickin A. Shah, MD |
|
|
Dr. Avinash Prabhakar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua M. Wilfong, DO |
|
|
Dr. Sandeep Vijan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Davoren A. Chick, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark C. Oberdoerster, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua M. Ruch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas W. Blayney, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian M. Renard, MD |
|
|
Dr. Christopher D. Lao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samuel M. Silver, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marian G. Boxer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sofia D. Merajver, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Huong T. Nguyen, MD
This Doctor is OpenDoctor Recommended.
|